Eyeworld

EW NEWS & OPINION 8 August 2015 of utilizing multidose eye drops on multiple patients, when proper protocols are followed. Further- more, diluting 10% povidone-iodine for surgical prophylaxis remains a common and appropriate option in preparing the surgical prophylaxis. ASCRS continued from page 3 IMPORTANT SAFETY INFORMATION FOR THE TECNIS ® MONOFOCAL 1-PIECE IOL (CONTINUED) Rx Only ATTENTION: Reference the Directions for Use for a complete listing of Indications and Important Safety Information. WARNINGS: Do not attempt to disassemble, modify or alter the device or any of its components. Do not use methylcellulose viscoelastics with the device. Do not implant the lens if the rod tip does not advance the lens or if it is jammed in the cartridge. Do not push the plunger forward to fully advance the lens until ready for lens implantation. Discard if the lens has been fully advanced for more than 1 minute. The lens should not be placed in the ciliary sulcus. PRECAUTIONS: Do not reuse, resterilize, or autoclave. ADVERSE EVENTS: In 3.3% of patients, reported adverse events of cataract surgery with the 1-Piece IOL included macular edema. IMPORTANT SAFET Y INFORMATION FOR THE TECNIS ® MONOFOCAL 1-PIECE IOL WITH TECNIS iTEC PRELOADED DELIVERY SYSTEM Rx Only ATTENTION: Reference the Directions for Use for a complete listing of Indications and Important Safety Information. PRECAUTIONS: Do not reuse, resterilize, reprocess, or autoclave the device. Do not store in direct sunlight or at a temperature under 5°C (41°F) or over 35°C (95°F). The recommended temperature for implanting the lens is at least 17°C. Low operating room temperatures combined with high IOL diopter powers may require slower delivery. The use of viscoelastics is required when using the device. The use of balance salt solution alone is not recommended. Do not use if the device has been dropped or if any part was inadvertently struck while outside the shipping case. WARNINGS: Do not attempt to disassemble, modify or alter the device or any of its components. Do not use methylcellulose viscoelastics with the device. Do not implant the lens if the rod tip does not advance the lens or if it is jammed in the cartridge. Do not push the plunger forward to fully advance the lens until ready for lens implantation. Discard if the lens has been fully advanced for more than 1 minute. The lens should not be placed in the ciliary sulcus. ADVERSE EVENTS: The most frequently reported adverse event that occurred during the clinical trial of the 1-Piece IOL was cystoid macular edema, which occurred at a rate of 3.3%. TECNIS and TECNIS iTec are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. www.AbbottMedicalOptics.com © 2015 Abbott Medical Optics Inc. | PP2015CT0742 One click away ... Read , search, and share current and past issues DIGITAL.EYEWORLD.ORG " We want to defend those facilities that choose to use multiuse bottles or dilute 10% Betadine, based on the best medical judgment of their clinical staff. " –David F. Chang, MD This position statement is provided for information and educational use only. It is not intended to establish a standard of care or dictate a particular course of treatment. ASCRS members and other physicians must exercise their independent medical judgment in making treatment decisions for their patients. "The Cataract Clinical Committee is not recommending or suggesting that there is only one best practice," Dr. Chang said. "Rather, we want to defend those facilities that choose to use multiuse bottles or dilute 10% Betadine, based on the best medical judgment of their clinical staff." EW Contact information Abbie Elliott: aelliott@ascrs.org

• Cover